Related Experiment Video
Updated: Aug 7, 2026
10:08
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
Published on: November 22, 2024
Platelet density in essential thrombocythemia and polycythemia vera
1Cardeza Foundation for Hematologic Research, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Platelets
|June 28, 2006
Summary
Platelet density is lower in patients with myeloproliferative disorders like essential thrombocythemia and polycythemia vera compared to healthy individuals. This finding suggests platelet density measurement can help diagnose these conditions.
Area of Science:
- Hematology
- Oncology
- Medical Diagnostics
Background:
- Myeloproliferative neoplasms (MPNs) are a group of blood cancers characterized by the overproduction of one or more types of blood cells.
- Essential thrombocythemia (ET) and polycythemia vera (PV) are common MPNs that affect platelet and red blood cell production, respectively.
- Accurate diagnosis and differentiation of MPNs are crucial for appropriate patient management and treatment.
Purpose of the Study:
- To investigate and compare platelet density in patients diagnosed with essential thrombocythemia (ET) and polycythemia vera (PV).
- To assess the potential utility of measuring platelet density peaks as a diagnostic marker for ET and PV.
- To establish reference ranges for platelet density in healthy individuals for comparison.
Main Methods:
- Density-separated platelets from patients with ET/PV and healthy controls were analyzed.
- A specialized apparatus was utilized to measure variations in light transmission, determining platelet density peaks.
- Statistical analysis was performed to compare platelet density between patient groups and the control group.
Main Results:
- Patients with myeloproliferative disorders (ET and PV) exhibited significantly lower mean platelet peak density compared to healthy volunteers (P < 0.001).
- A low platelet density peak was associated with a higher likelihood of a clonal disorder, supporting suspicion of ET or PV.
- Conversely, a high platelet density peak suggested a lower probability of these myeloproliferative neoplasms.
Conclusions:
- Measurement of platelet density peaks may serve as a valuable diagnostic aid in the investigation of suspected essential thrombocythemia and polycythemia vera.
- This method could potentially assist in excluding ET and PV when results fall within the normal range.
- Further research may explore the integration of platelet density analysis into routine diagnostic algorithms for MPNs.
Related Concept Videos
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...